D. Riveros

发表

Polymyalgia rheumatica in patients with myelodysplastic syndromes.

O. Hubscher, A. Vilches, S. Solmesky, 1996, The Journal of rheumatology.

Convalescent plasma as potential therapy for severe COVID-19 pneumonia.

F. Pálizas, D. Riveros, R. Valentini, 2020, medRxiv.

Combination salvage chemotherapy with MIZE (ifosfamide-mesna, idarubicin and etoposide) for relapsing or refractory lymphoma.

C. Albera, E. Triguboff, D. Riveros, 1997, Leukemia & lymphoma.

Cerebral Arteritis Following Methylphenidate Use

A. Lazarowski, D. Riveros, S. Garbugino, 2000, Journal of child neurology.

Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from grupo argentino de mieloma múltiple

D. Fantl, P. Ochoa, P. Duarte, 2021, Expert review of hematology.

Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.

J. Zorzópulos, D. Riveros, J. Solimano, 2006, Medicina.

OLIGONUCLEOTIDE IMT 504 INDUCES AN IMMUNOGENIC PHENOTYPE AND APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

M. Salón, J. Zorzópulos, D. Riveros, 2006 .

Congenital factor XIII deficiency associated with von willebrand disease

N. Maugeri, M. Lazzari, D. Riveros, 1990, American journal of hematology.

Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies

P. Lev, R. Marta, N. Goette, 2016, PloS one.

99mTechnetium-SESTAMIBI uptake in malignant lymphomas. Correlation with chemotherapy response.

D. Riveros, J. Solimano, J. Dupont, 2006, Lymphatic research and biology.

Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.

Christian Chena, I. Slavutsky, I. Larripa, 2005, Cancer genetics and cytogenetics.

Carotid and Vertebral Artery Dissection Syndromes.

D. Riveros, J. Solimano, B. Grand, 2005 .

Ruxolitinib In Myelofibrosis (MF) Patients Through Compassionate Use Program (CUP). Argentinian Experience

G. Remaggi, A. Corzo, S. Orlando, 2013 .

Lupus anticoagulant, anti-Ro (SS-A) antibodies, and fetal wastage in systemic lupus erythematosus.

O. Hubscher, D. Riveros, A. Eimon, 1988, Arthritis and rheumatism.

Hemoglobin concentration variations over time in general medical inpatients.

S. Marciano, F. Poletta, Agustín Languasco, 2010, Journal of hospital medicine.

[Antiphospholipid antibodies in patients with vestibular manifestations. A study of 16 cases].

S. Ameriso, D. Riveros, G. Gárate, 2003, Revista de neurología (Ed. impresa).

Laboratory identification of the lupus anticoagulant in normal pregnancy and pregnancy-induced hypertension.

L. Voto, M. Lazzari, D. Riveros, 1990, American journal of obstetrics and gynecology.

1-17-22 High expression of multidrug resistance gene (MDR-1) and persistant low levels of phenytoin (PHT) on a patient with refractary epilepsy due to tuberous sclerosis (TS)

A. Rabinowicz, G. Sevlever, A. Lazarowski, 1997, Journal of the Neurological Sciences.

Toxicity and Outcomes of Ibrutinib in Chronic Lymphatic Leukemia-Real-World Results from the Study of 215 Patients in Argentina

M. Zerga, H. Fernández Grecco, A. Pavlovsky, 2023, International Journal of Clinical and Experimental Medical Sciences.

Hemoglobin concentration variations over time in general medical inpatients.

S. Marciano, F. Poletta, Agustín Languasco, 2010, Journal of hospital medicine.